Dosage of Tacrolimus Metabolites in Blood and Bile for Prediction of Its Side Effects in Liver Transplant Recipients

Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells

NCT03654794 ·Status: COMPLETED

Pharmacogenetic Study of Tacrolimus in Hepatic Transplant (CYPTAC'H)

NCT01388387 ·Status: COMPLETED ·Phase: NA

Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation

NCT00151632 ·Status: TERMINATED ·Phase: PHASE3

Long-Term Pharmacokinetics of Tacrolimus in Renal Recipients

NCT00411944 ·Status: COMPLETED

Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients

NCT03020589 ·Status: COMPLETED ·Phase: PHASE4

Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients

NCT01760356 ·Status: TERMINATED

Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients

NCT06183892 ·Status: RECRUITING ·Phase: NA

Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts

NCT00321074 ·Status: COMPLETED ·Phase: PHASE3

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

NCT00469131 ·Status: COMPLETED ·Phase: PHASE3

Analysis of the Effect of Donor CYP3A5 Gene Polymorphism on Early Tacrolimus Concentration and Postoperative Acute Renal Injury After Liver Transplantation

NCT06319391 ·Status: ACTIVE_NOT_RECRUITING

The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma

NCT04657562 ·Status: UNKNOWN

A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

NCT00451932 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

NCT04102943 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients

NCT02337036 ·Status: UNKNOWN ·Phase: NA

Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)

NCT06354179 ·Status: RECRUITING ·Phase: PHASE4

Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients

NCT05744635 ·Status: RECRUITING

Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors

NCT00456235 ·Status: COMPLETED ·Phase: PHASE4

Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation

NCT02064777 ·Status: UNKNOWN ·Phase: PHASE4

PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients

NCT00178425 ·Status: COMPLETED ·Phase: PHASE4

Blood-Bile Ratio Tacrolimus After Liver Transplantation

NCT03882164 ·Status: UNKNOWN

Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation

NCT00975663 ·Status: TERMINATED ·Phase: PHASE4

Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing

NCT00028171 ·Status: COMPLETED ·Phase: NA

Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidney Transplant Patients

NCT05872815 ·Status: UNKNOWN

Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation

NCT00297310 ·Status: COMPLETED ·Phase: PHASE4

Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

NCT00717379 ·Status: COMPLETED ·Phase: PHASE4